Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Goosehead Insurance, Inc. to Report Second Quarter 2024 Results
-
Defiance Announces 1-for-3 Reverse Stock Split of QQQY, JEPY, and IWMY ETFs
-
The Defiance Treasury Alternative Yield ETF (TRES) to Close
-
Scorpio Tankers Inc. Announces That on July 30, 2024, the Company Plans to Issue Its Second Quarter 2024 Results and Have a Conference Call
-
Globally renowned thought leaders Joy Fitzgerald, Suzy Welch, and Lan Phan to headline the 2024 INROADS National Conference
-
Transocean Ltd. Announces Second Quarter 2024 Earnings Release Date
-
Rapid Micro Biosystems to Announce Second Quarter 2024 Financial Results on August 2, 2024
-
Nayax to Report 2024 Q2 Earnings on August 7, 2024
-
Reservoir Media to Release First Quarter Fiscal 2025 Results on July 31, 2024
-
Fidelity D & D Bancorp, Inc. Third Quarter 2024 Dividend
-
Norwegian Cruise Line Holdings to Hold Conference Call on Second Quarter 2024 Financial Results
-
Scorpius Holdings Announces Reverse Stock Split
-
Teladoc Health to Announce Second Quarter 2024 Financial Results
-
Mercer International Inc. Receives Improved ESG Risk Rating from Sustainalytics
-
SL Green Realty Corp. Reports Second Quarter 2024 EPS of ($0.04) Per Share; and FFO of $2.05 Per Share
-
SL Green Signs Retail Leases Totaling More Than 66,000 Square Feet
-
SL Green Announces Sale Closings Totaling $691 Million
-
Jamf to Report Second Quarter 2024 Financial Results on August 7, 2024
-
Village Super Market, Inc. Announces the Passing of Its Chairman of the Board William Perry Sumas
-
Wintrust Financial Corporation Reports Record Year-to-Date Net Income
-
Paycor Announces Date of Fourth Quarter and Fiscal Year 2024 Financial Results
-
ValOre Continues Trado® Drill and Trenching Exploration Programs at Salvador Target, Pedra Branca PGE Project, Brazil
-
Carriage Services Declares Quarterly Cash Dividend
-
Richardson Electronics Announces Date of Fourth Quarter Fiscal Year 2024 Conference Call
-
Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal
-
Royalty Pharma Declares Third Quarter 2024 Dividend
-
ESCO Technologies Announces Third Quarter 2024 Earnings Release And Conference Call
-
Compass Diversified Announces Second Quarter 2024 Earnings and Conference Call Information
-
OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments
-
Promising Preliminary Results in Optic Nerve Recovery Study of NurExone’s first product ExoPTEN for Glaucoma
-
SL Green Announces Sellout of Giorgio Armani Residences at 760 Madison Avenue
-
Douglas Dynamics Announces Second Quarter 2024 Earnings Release and Conference Call
-
EverQuote to Announce Second Quarter 2024 Financial Results on August 5, 2024
-
Angi Inc. to Announce Q2 2024 Earnings on August 6th and Host Earnings Conference Call on August 7th
-
Coca-Cola Consolidated, Inc. To Release Second Quarter and First Half 2024 Results
-
Crown Castle Reports Second Quarter 2024 Results and Maintains Outlook for Full Year 2024
-
Triumph Financial Releases Second Quarter 2024 Financial Results
-
INNOVATE Corp. to Report Second Quarter 2024 Results on August 7th
-
MYR Group Inc. Announces Second-Quarter 2024 Earnings Release and Conference Call Schedule
-
Southern States Bancshares, Inc. Announces Quarterly Cash Dividend of $0.09 Per Share
-
Brink’s Schedules Second-Quarter 2024 Earnings Release and Conference Call for August 7, 2024
-
Allbirds Announces Second Quarter 2024 Earnings Conference Call
-
Methode Electronics Names John T. Erwin as Chief Procurement Officer
-
Leslie’s, Inc. Announces Preliminary Third Quarter Fiscal 2024 Financial Results and Provides Updated Full-Year Outlook
-
Highwoods Declares Quarterly Dividends
-
SL Green Office Leasing Volume Exceeds 1.4 Million Square Feet in 2024
-
PetIQ, Inc. to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
-
Horizon Bank Appoints Michele Samuels and Brian Walker to Serve as Independent Directors
-
Ultragenyx Announces Successful End-of-Phase 2 Meeting with FDA for GTX-102 Angelman Syndrome Program
-
Encore Capital Group to Announce Second Quarter 2024 Financial Results on August 7

